Pharmac in NZ to provide 18,000 type 1 diabetes patients with CGMs and AID systems, despite potential access limitations.

Pharmac, New Zealand's health funding body, will provide continuous glucose monitors and automated insulin delivery systems for 18,000 individuals with type 1 diabetes, following advocacy efforts. However, a significant healthcare workforce shortage may limit access, particularly for Māori and Pacific groups. While these technologies improve diabetes management and reduce hospitalizations, training for their use could take years, potentially exacerbating health disparities.

October 16, 2024
7 Articles